UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Mar

    06

    Press Release: UCB Ventures Appoints Alicia Irurzun-Lafitte as Partner

    Mar

    02

    Press Release: Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study

    Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study

    Mar

    01

    Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio

    New Data Affirms Strength of UCB Immuno-Dermatology Portfolio

    Feb

    28

    Welcoming AAD to Washington, D.C.

    We’re excited to welcome the 2019 American Academy of Dermatology (AAD) meeting to Washington, D.C. this week. As AAD comes to town, we wanted to offer a few recommendations from our D.C. staff. UCB’s D.C. office focuses on public policy with colleagues in advocacy, policy, public affairs, and regulatory.

    Feb

    27

    It’s Not Because It’s ‘Rare’ that We Care

    For International Rare Disease Day, our Global Head of the Rozimab Mission, Chris Clark, shares insights about how UCB is leveraging and growing our capabilities to deliver value for specific patient populations new to UCB. Read the full article on LinkedIn.

    Feb

    14

    Our Innovation Journey: From Patient to Science to Solution

    With Innovation Day upcoming on February 17, we’re highlighting our approach to innovation, what we call at UCB the “patient-science-solution” model. Everything we do starts and ends with what patients value, but it is a continuous journey. Starting with the patient – we listen to their experiences, what they value, their needs, and keep them at the heart of everything we do.

    Feb

    06

    Volunteerism Amplifies Our Mission

    Jan

    29

    How the Big Game in Atlanta Inspires UCB’s Game Plan

    With an estimated 75,000 people coming to Atlanta for the Big Game and over 100 million tuning in to watch it, Duane Barnes, former college football player and UCB’s President, Head of U.S. Operations talks about how having the game in our backyard helps us to reflect on our game plan to deliver wins for patients. Read the full article on LinkedIn.

    Jan

    10

    Patients Propel Scientific Discovery

    Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and focusing us on what patients value. At UCB, we want to help people live their best lives, whatever that means for them. So, every day, we come together to work, laser-focused, on a simple question: How will this create value for people living with severe diseases?

    Jan

    07

    Growing our Footprint in Boston and Seattle

    In 2019, we look forward to continuing our journey to grow our impact. Our future has never been brighter and the opportunities to provide patients with solutions they value has never been more urgent. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, solutions are on the horizon to help more patients managing severe diseases live their best lives.